XYL insider notice: 1,000 shares via Morgan Stanley worth $139,962
Rhea-AI Filing Summary
Xylem Inc. (XYL) Form 144 notifies a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $139,962. The filing lists the issuer's outstanding common shares as 243,409,688, and shows an approximate sale date of 09/05/2025. The shares reported were acquired primarily via the company's Employee Stock Purchase Plan in multiple small purchases between 03/23/2023 and 03/01/2024, with the largest single acquisition entries totaling 477, 322, and 136 shares.
The notice contains no reportable sales in the past three months and includes the standard representation that the seller is unaware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice for a small block of shares acquired through ESPP; likely immaterial to XYL's valuation.
This Form 144 reports a proposed sale of 1,000 common shares valued at about $140k against ~243.4 million outstanding shares, representing an immaterial dilution and ownership change. The holdings were accumulated through an Employee Stock Purchase Plan in small tranches, indicating personal liquidity rather than strategic disposition. No recent sales in the prior three months are reported, and there is a standard certification regarding material nonpublic information. Overall, this is a routine disclosure with limited investor impact.
TL;DR: Compliance filing shows planned broker-assisted sale; governance and disclosure procedures appear followed.
The notice identifies Morgan Stanley Smith Barney as the executing broker and provides required acquisition history for the securities to be sold, demonstrating compliance with Rule 144 aggregation and disclosure rules. The seller affirms no undisclosed material adverse information and the form contains the customary legal notice about intentional misstatements. There are no indications of coordination with other significant holders or unusual transaction structures in the provided data.
FAQ
What does the Form 144 filed for Xylem Inc. (XYL) disclose?
How many Xylem (XYL) shares are outstanding according to the filing?
How were the shares being sold acquired?
Were there any Xylem (XYL) sales by this person in the past three months?
Which broker will execute the proposed sale of XYL shares?